The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.


U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
Trump Expands U.S. Travel Ban to Antigua and Barbuda, Dominica, Sparking Economic Fears in the Caribbean
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge
Trump Administration Proposes Sweeping Limits on Gender-Affirming Care for Children
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 



